Company Name | Amanta Healthcare Ltd |
Exchange | NSE, BSE |
Share Price | ₹126 |
Open Date | 01-September-2025 |
Close Date | 03-September-2025 |
List Date | 08-September-2025 |
Face Value | 10 |
Lot Size | 119 |
Amanta Healthcare Ltd About Us
At Amanta Healthcare, we believe that virtually every part of the company must strive to innovate, to evolve, to change with the objective of achieving greater levels of competitive advantage.
Keeping pace with change has been our mantra for growth. A mantra called Innovision. A mantra that has been so internalized, that from being a large volume parenterals and IV parenteral formulations manufacturing company that commenced operations in 1998, today we have evolved into a company whose business interests include production of irrigation solutions, formulations in ophthalmic and respiratory care and small volume injectables making us a leading player with a wide variety of large and small volume preparations in sterile dosage forms.
for more visit our website:https://www.amanta.co.in/
Amanta Healthcare Ltd IPO Financials
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
Assets | 381.76 | 352.12 | 374.06 |
Total Income | 276.09 | 281.61 | 262.70 |
Profit After Tax | 10.50 | 3.63 | -2.11 |
EBITDA | 61.05 | 58.76 | 56.31 |
Net Worth | 96.39 | 66.29 | 62.88 |
Reserves and Surplus | 67.56 | 39.46 | 36.05 |
Total Borrowing | 195.00 | 205.23 | 215.66 |
Amount in ₹ Crore |
Amanta Healthcare Ltd IPO Allotment Status:
Allotment Link | https://linkintime.co.in/Initial_Offer/public-issues.html |
Amanta Healthcare Ltd Website | https://www.amanta.co.in/ |